The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis
P Laissue - Molecular cancer, 2019 - Springer
Colorectal cancer (CRC) is the third most commonly occurring cancer worldwide and the
fourth most frequent cause of death having an oncological origin. It has been found that …
fourth most frequent cause of death having an oncological origin. It has been found that …
Transcription factors in colorectal cancer: molecular mechanism and therapeutic implications
Colorectal cancer (CRC) is a major cause of cancer mortality worldwide, however, the
molecular mechanisms underlying the pathogenesis of CRC remain largely unclear. Recent …
molecular mechanisms underlying the pathogenesis of CRC remain largely unclear. Recent …
[HTML][HTML] The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update
Cancer immunity is regulated by several mechanisms that include co-stimulatory and/or co-
inhibitory molecules known as immune checkpoints expressed by the immune cells. In …
inhibitory molecules known as immune checkpoints expressed by the immune cells. In …
Quinazolinone derivatives: Synthesis and comparison of inhibitory mechanisms on α-glucosidase
M Wei, WM Chai, R Wang, Q Yang, Z Deng… - Bioorganic & Medicinal …, 2017 - Elsevier
In this study, eight quinazolinone derivatives were designed and synthesized. Their
inhibitory activities on α-glucosidase were assessed in vitro. Two compounds: 2-(4 …
inhibitory activities on α-glucosidase were assessed in vitro. Two compounds: 2-(4 …
Impediment of cancer by dietary plant-derived alkaloids through oxidative stress: implications of PI3K/AKT pathway in apoptosis, autophagy, and ferroptosis
The adverse toxicities and stemness are two major factors that constrained the usage of
therapeutic strategies to target several cancer types. Previous studies explored the efficacy …
therapeutic strategies to target several cancer types. Previous studies explored the efficacy …
[HTML][HTML] FOXOs in the impaired heart: New therapeutic targets for cardiac diseases
Z **n, Z Ma, S Jiang, D Wang, C Fan, S Di, W Hu… - … et Biophysica Acta (BBA …, 2017 - Elsevier
Cardiac diseases have a high morbidity and mortality and affect the global population.
Based on recent accumulating evidence, Forkhead box O (FOXOs) play important roles in …
Based on recent accumulating evidence, Forkhead box O (FOXOs) play important roles in …
Cytotoxic quinazoline alkaloids from the seeds of Peganum harmala
SG Li, KB Wang, C Gong, Y Bao, NB Qin, DH Li… - Bioorganic & medicinal …, 2018 - Elsevier
Seventeen quinazoline alkaloids and derivatives, containing two pairs of new epimers,
named as (S)-and (R)-1-(2-aminobenzyl)-3-hydroxypyrrolidin-2-one β-d-glucopyranosyl …
named as (S)-and (R)-1-(2-aminobenzyl)-3-hydroxypyrrolidin-2-one β-d-glucopyranosyl …
CXCL16/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K/AKT/FOXO3a pathway
Z Ma, R Yu, Q Zhu, L Sun, L Jian, X Wang… - International …, 2020 - Elsevier
Objective Interstitial lung disease (ILD) is a progressive and irreversible lung disease with
very limited therapeutic options. Previous studies have found that chemokine ligands …
very limited therapeutic options. Previous studies have found that chemokine ligands …
Natural bioactive compounds and FOXO3a in cancer therapeutics: an update
S Manoharan, K Prajapati, E Perumal - Fitoterapia, 2024 - Elsevier
Forkhead box protein 3a (FOXO3a) is a transcription factor that regulates various
downstream targets upon its activation, leading to the upregulation of tumor suppressor and …
downstream targets upon its activation, leading to the upregulation of tumor suppressor and …
[HTML][HTML] PI3K inhibitor 3-MA promotes the antiproliferative activity of esomeprazole in gastric cancer cells by downregulating EGFR via the PI3K/FOXO3a pathway
J Du, Q Xu, H Zhao, X Jia, N Ba, F Peng… - Biomedicine & …, 2022 - Elsevier
Gastric cancer is a common gastrointestinal malignancy worldwide, with a high mortality rate
and poor prognosis. Esomeprazole (ESO) has been shown to have anticancer activity by …
and poor prognosis. Esomeprazole (ESO) has been shown to have anticancer activity by …